Condition
Myotonic Dystrophy 1 clinical trials and research
As of November 12, 2026, Find a Trial lists 10 Myotonic Dystrophy 1 clinical trials that are recruiting, at sites in 17 countries (most in United States (4), Canada (4), United Kingdom (3)). By phase: Phase 2 (2), Phase 1/2 (1), Phase 3 (1). The most active sponsors are Virginia Commonwealth University (2), PepGen Inc (2), Centre Hospitalier Universitaire de Liege (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 10Clinical trials
- 17Countries
Newest Myotonic Dystrophy 1 clinical trials
All recruiting trials (10)
-
Understanding long-term progression in myotonic dystrophy type 1 (DM1)
This study will follow adults with DM1 for at least four years to see how walking, hand function, muscle strength, heart rhythms, and lung function change over time.
-
Spanish National Registry for Myotonic Dystrophy Type 1
This registry gathers health, clinical, and genetic information from people in Spain with DM1 to see how the condition changes over time and help match patients to future trials.
-
Long-term PGN-EDODM1 extension for people with myotonic dystrophy type 1
This open-label extension will try continued PGN-EDODM1 in people with myotonic dystrophy type 1 who completed a prior PGN-EDODM1 study to see how safe and tolerable it is over time.
-
Wearable monitoring of walking and arm movement in adults with neuromuscular or metabolic movement disorders
This project uses a wrist/ankle wearable to continuously monitor walking and upper-limb movement in ambulant adults with neuromuscular diseases or obesity to see if digital measures like stride speed track real-life motor function.
-
Investigating PGN-EDODM1 for Myotonic Dystrophy Type 1
This study is testing a new medication called PGN-EDODM1 to see if it is safe and well-tolerated in people with myotonic dystrophy type 1.
-
Testing ATX-01 for myotonic dystrophy type 1
This study is testing a new drug called ATX-01 to see if it is safe and well-tolerated in people with myotonic dystrophy type 1.
-
Collecting data on muscle disorders using wearable devices
This study is testing a wearable device to track movement in people with muscle disorders like Duchenne Muscular Dystrophy and Myotonic Dystrophy to see how it can help improve their care.
-
Metformin to improve muscle strength in myotonic dystrophy type 1
This will test whether taking metformin can improve muscle strength and daily function in adults with myotonic dystrophy type 1 who can still walk.
-
Identifying biomarkers and clinical endpoints in Myotonic Dystrophy Type 1
This study is trying to learn more about Myotonic Dystrophy Type 1 by looking at how the disease affects around 700 adults over two years, including their muscle health and daily activities.
-
Online registry for myotonic dystrophy patients
This study is creating an online registry for people with myotonic dystrophy to share their experiences and help researchers find better treatments.
Related topics
Quick answers
How many Myotonic Dystrophy 1 clinical trials are recruiting right now?
10, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 17 countries. The most sites are in United States (4 trials), Canada (4 trials), United Kingdom (3 trials), New Zealand (2 trials), France (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 1/2: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.